Form 8-K - Current report:
SEC Accession No. 0001731122-24-000372
Filing Date
2024-03-07
Accepted
2024-03-07 17:00:34
Documents
14
Period of Report
2024-03-01
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e5476_8k.htm   iXBRL 8-K 25109
  Complete submission text file 0001731122-24-000372.txt   198009

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE renb-20240301.xsd EX-101.SCH 3024
3 XBRL LABEL FILE renb-20240301_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE renb-20240301_pre.xml EX-101.PRE 22365
15 EXTRACTED XBRL INSTANCE DOCUMENT e5476_8k_htm.xml XML 3613
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO INC. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38758 | Film No.: 24731069
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)